Sign Up to like & get recommendations! 1
Published in 2021 at "Human pathology"
DOI: 10.1016/j.humpath.2021.12.002
Abstract: BACKGROUND Gestational trophoblastic diseases (GTD) are a heterogeneous group of lesions, the most frequent being the hydatidiform mole (HM). HM are usually cured after surgical treatment or after chemotherapy in the case of a persistent… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-46660-4
Abstract: Hydatidiform moles are known to pose an extremely high risk of severe early-onset preeclampsia if left untreated. TNF superfamily cytokine, LIGHT has recently been reported to contribute to pathophysiology of preeclampsia. The present study aimed… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Nutrition and Cancer"
DOI: 10.1080/01635581.2022.2079688
Abstract: Abstract The current ecological study aims to explore the association between dietary factors and hydatidiform mole (HM) incidence in Japan and China. HM incidence in Japan gradually declined from 1970s to 1990s, while the dietary… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033438
Abstract: Rationale: Placental mesenchymal dysplasia (PMD) is a rare placental disease frequently associated with severe maternal and/or fetal complications. Its sonographic appearance is very similar to that of a hydatidiform mole. Hence, PMD is easily misdiagnosed… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2021-002797
Abstract: Objective To assess the strategy and value of centralized surveillance of hydatidiform mole at a regional hospital in China and to investigate the necessity of prophylactic chemotherapy for high-risk complete hydatidiform mole. Methods Between February… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "BMC Cancer"
DOI: 10.1186/s12885-017-3749-8
Abstract: BackgroundThere are three main therapeutic strategies, namely expectant management (dilation and curettage only), prophylactic chemotherapy and prophylactic total hysterectomy for treating older women with complete hydatidiform mole (CHM). However, the scientific community has so far,… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "ACTA MEDICA IRANICA"
DOI: 10.18502/acta.v57i1.1750
Abstract: Abstract- Morphologic examination still forms the main diagnostic tool in the differential diagnosis of molar placentas. However the criteria are subjective and show considerable inter-observer variability among pathologists. The aim of the present study was… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.20769
Abstract: Complete hydatidiform mole (CHM) is a rare pregnancy-related disease with invasive potential. The genetics underlying the sporadic form of CHM have not been addressed previously, but maternal genetic variants may be involved in biparental CHM.… read more here.